EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metformin suppresses PPARδ-driven CD47 transcription to enhance macrophage phagocytosis in lung cancer

Qian Cui, Huijie Wang, Hongxu Yu, Yinghan Li, Yelei Wang, Juanjuan Shi, Yongzhong Hou

Journal of Biological Chemistry · 2026

DOI: 10.1016/j.jbc.2026.111159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Qian Cui und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, Jiangsu University, Zhenjiang, Jiangsu Province, People's Republic of China. Hauptthemen laut MEDLINE: Metformin, CD47 Antigen, Lung Neoplasms, Phagocytosis. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metformin, an activator of AMP kinase, influences critical cellular processes, including proliferation, metabolism, inflammation, and immunity. However, its specific impact on macrophage-mediated phagocytosis of tumor cells remains poorly characterized. Our study demonstrates that metformin treatment substantially decreases both CD47 protein and mRNA levels in lung cancer cells. This reduction stems from metformin's suppression of CD47 gene transcription. Consequently, metformin enhances macrophage phagocytic activity against cancer cells. In vivo analyses using a tumor implantation model revealed that metformin impedes tumor immune escape. This effect correlates with diminished CD47 expression within tumors and heightened macrophage phagocytosis. Furthermore, combining metformin with an anti-CD47 antibody synergistically augmented antitumor immunotherapy efficacy. Mechanistically, metformin attenuates peroxisome proliferator-activated receptor delta-mediated CD47 transcriptional activation and subsequent gene expression. These results elucidate a novel mechanism by which metformin counteracts tumor immune evasion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminCD47 AntigenLung NeoplasmsPhagocytosisMacrophagesPPAR deltaTranscription, GeneticHumansAnimalsMiceCell Line, Tumor

Stichwörter der Autor:innen

CD47PPARδimmune evasionmetforminphagocytosis

Substanzen

MetforminCD47 AntigenPPAR deltaCD47 protein, human

Autor:innen und Institutionen

  • School of Life Science, Jiangsu University, Zhenjiang, Jiangsu Province, People's Republic of China.
  • School of Life Science, Jiangsu University, Zhenjiang, Jiangsu Province, People's Republic of China. Electronic address: houyz@ujs.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Cui, Q., Wang, H., Yu, H., Li, Y., Wang, Y., Shi, J., & Hou, Y. (2026). Metformin suppresses PPARδ-driven CD47 transcription to enhance macrophage phagocytosis in lung cancer. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2026.111159

Vancouver

Cui Q, Wang H, Yu H, Li Y, Wang Y, Shi J, et al. Metformin suppresses PPARδ-driven CD47 transcription to enhance macrophage phagocytosis in lung cancer. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2026.111159

BibTeX
@article{Cui2026,
  author = {Cui, Qian and Wang, Huijie and Yu, Hongxu and Li, Yinghan and Wang, Yelei and Shi, Juanjuan and Hou, Yongzhong},
  title = {Metformin suppresses PPARδ-driven CD47 transcription to enhance macrophage phagocytosis in lung cancer},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  doi = {10.1016/j.jbc.2026.111159}
}
Kostenlos starten →